Calidi Biotherapeutics, Inc. (CLDI) AI Dilution Summary

Estimated cash was $2,221,981 as of 2026-09-21, rolled forward from $4,071,000 at 2026-06-30 against estimated monthly burn of $1,411,500. The most recent raise was a registered direct offering closed 2026-09-21: 1,025,640 shares at $1.17 per share for $1,200,000 gross and $1,100,000 net. Dilution here is driven primarily by the active ATM program with Ladenburg Thalmann & Co. Inc., authorised to $11,200,000 with $1,300,000 of remaining capacity.